🚨 General Meeting · CPHL The prior announcement regarding the Extraordinary General Meeting of Citi Pharma Ltd. has been revoked. However, the resolutions adopted during the meeting held on July 8, 2026, are confirmed, including the approval of a Scheme of Arrangement and Demerger.
- Meeting Type: Extraordinary General Meeting (EOGM)
- Date & Time: July 8, 2026, at 2:00 p.m.
- Venue: Head Office, 588-Q, Johar Town, Lahore
- Agenda Item: Confirmation of the Minutes of the Annual General Meeting held on October 27, 2025
- Special Resolution: Approval of the Scheme of Arrangement and Demerger with Citi Core Holdings (Private) Limited
- Votes in Favor: 129,999,854 (99.99% of votes cast)
- Votes Against: 15,722 (0.01% of votes cast)
- Total Members Present: 145, representing 130,015,576 shares (56.91% of total capital)
About this brief: prepared automatically by BSL’s research systems from the company’s filing with the exchange. A summary for information, not investment advice — the original filing is the authoritative record.
Original filing (PDF)